Vesicoureteric reflux in children: many questions still unanswered


Authors: MUDr. Ph.D. Jakub Zieg
Authors‘ workplace: Pediatrická klinika 2. LF UK a FN Motol
Published in: Čas. Lék. čes. 2016; 155: 141-144
Category: Review Article

Overview

Vesicoureteric reflux (VUR) is the most common congenital anomaly of the uropoetic system. The gold standard for its diagnosis is the voiding cystourethrogram. Sonographic cystourethrography is an alternative method for reflux detection, but it is still not used routinely. Static scintigraphy enables us to diagnose renal scarring − reflux nephropathy (RN). While congenital RN is a result of prenatal kidney injury, acquired RN results from pyelonephritis-induced renal damage.

Risk factors for RN include VUR, recurrent APN, lower urinary tract dysfunction and delay in treatment of febrile urinary tract infection. Management of children after APN with VUR consists of antibiotic prophylaxy, surgery or surveillance only. The conclusions of performed studies are controversial, thus unified guidelines for the management of patients with VUR are not available.

Keywords:
vesicoureteric reflux, reflux nephropathy, urinary tract infections, children


Sources

1. Lebowitz RL, Olbing H, Parkkulainen KV et al. International system of radiographic grading of vesi­coureteric reflux. International Reflux Study in Children. Pediatr Radiol 1985; 15:105−109.

2. Gonzalez E, Papazyan JP, Girardin E. Impact of vesicoureteral reflux on the size of renal lesions after an episode of acute pyelonephritis. J Urol 2005; 173: 571–574.

3. Hoberman A, Charron M, Hickey RW et al. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003; 348: 195−202.

4. Feather SA, Malcolm S, Woolf AS et al. Primary, nonsyndromic vesicorureteric reflux and its nephropathy is genetically heterogeneous,with a locus on chromosome 1. Am J Hum Genet 2000; 66: 1420−1425.

5. Reiterová J, Merta M. Genetické aspekty nefrologických onemocnění. Medicína pro praxi 2008; 5: 423−425.

6. Mlynářová E. Doporučený postup pro provedení mikční cystouretrografie u dětí. Čes Radiol 2013; 67: 263−269.

7. Matoo TK. Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis 2011 Sep; 18: 348−354.

8. NAPRTCS. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Annual Report 2008.

9. Zhang Y, Bailey RR. A long term follow up of adults with reflux nephropathy. N Z Med J 1995; 108: 142−144.

10. Silva JM, Santos Diniz JS, Marino VS et al. Clinical course of 735 children and adolescents with primary vesicoureteric reflux. Pediatr Nephrol 2006; 21: 981−988.

11. Roberts KB, Downs SM, Finell SM et al. Urinary tract tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128: 595−610.

12. Mlynářová E, Zieg J, Sorantin E. Zobrazení močového traktu u dětí s febrilní infekcí močových cest ve věku 2 - 24 měsíců v centru terciální péče v České republice: zamyšlení nad současnými postupy. Čes Radiol 2013; 67: 253−259.

13. Duckett JW, Walker RD, Weiss R. Surgical results: International Reflux Study in Children-United States branch. J Urol 1992; 148: 1674−1675.

14. Holmdahl G, Brandström P, Läckgren G et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol 2010; 184: 280.

15. Tullus K. Vesicoureteric reflux in children. Lancet 2015; 385: 371−379.

16. Garin EH, Olavarria F, Garcia Nieto V et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006; 117: 626−632.

17. Montini G, Rigon L, Zucchetta P et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 2008; 122: 1064−1071.

18. Pennesi M, Travan L, Peratoner L et al.; North East Italy Prophylaxis in VUR study group. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 2008; 121: 1489−1494.

19. Craig JC, Simpson JM, Williams GJ et al. Prevention of Recurrent Urinary Tract Infection in Children. N Engl J Med 2009; 361: 1748−1759.

20. Brandström P, Jodal U, Sillén U et al. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. J Pediatr Urol 2011; 7: 594−600.

21. Hoberman A, Greenfield SP, Mattoo TK et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 2014; 370: 2367−2376.

22. Dítě Z. Dysfunkce dolních močových cest. Urologické listy 2007; 5: 42–45.

23. Fast AM, Nees SN, Van Batavia JP et al. Outcomes of targeted treatment for vesicoureteral reflux in children with nonneurogenic lower urinary tract dysfunction. J Urol 2013; 190: 1028−1032.

24. Elder JS, Diaz M. Vesicoureteral reflux-the role of bladder and bowel dysfunction. Nat Rev Urol 2013; 10: 640−648.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management fenix.admin.empty
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account